ArticleWorld journal of urology2021
Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up.
Akbar N Ashrafi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.